Although NASH is driven by metabolic inflammation, it is also accompanied by marked changes in the hepatic immune system, including the accumulation of immunosuppressive IgA-expressing plasma cells, which dismantle immunosurveillance by HCC-directed T cells (19, 20). Here, CD79A is linked to metabolic dysfunction-associated steatohepatitis.